Exact Mass: 381.0147

Exact Mass Matches: 381.0147

Found 57 metabolites which its exact mass value is equals to given mass value 381.0147, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-acetyl-D-glucosamine 1,6-bisphosphate

N-Acetyl-alpha-D-glucosamine 1,6-bisphosphate

C8H17NO12P2 (381.0226)

F5231

N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxotetrazol-1-yl]phenyl]ethanesulfonamide

C12H14ClF2N5O3S (381.0474)

Desacetycefapirin

7-{[1-hydroxy-2-(pyridin-4-ylsulphanyl)ethylidene]amino}-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H15N3O5S2 (381.0453)

Desacetycefapirin is a potential milk contaminant arising from the metabolism of cefapirin in cattle. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams Potential milk contaminant arising from the metabolism of cefapirin in cattle

5'-Carboxy meloxicam

2-{[hydroxy(4-hydroxy-2-methyl-1,1-dioxo-2H-1λ⁶,2-benzothiazin-3-yl)methylidene]amino}-1,3-thiazole-5-carboxylic acid

C14H11N3O6S2 (381.0089)

5-Carboxy meloxicam is a metabolite of meloxicam. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is a derivative of oxicam, closely related to piroxicam, and falls in the enolic acid group of NSAIDs. It was developed by Boehringer-Ingelheim. (Wikipedia)

N-Acetylgalactosamine 4,6-disulfate

N-[(3R,4R,5R,6R)-2,4-Dihydroxy-5-(sulphooxy)-6-[(sulphooxy)methyl]oxan-3-yl]ethanimidic acid

C8H15NO12S2 (381.0036)

N-Acetylgalactosamine 4,6-disulfate (GalNAc4,6diS) is one of the sulphated N-acetylhexosamines that have been isolated from human urine. PMID: 3931626. N-Acetylgalactosamine 4,6-disulfate (GalNAc4,6diS)is one of the sulphated N-acetylhexosamines that have been isolated from human urine.

dehydrofelodipine

3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate

C18H17Cl2NO4 (381.0535)

dehydrofelodipine is a metabolite of felodipine. Felodipine is a calcium channel blocker (calcium antagonist), a drug used to control hypertension (high blood pressure). It is marketed under the brand name Plendil by AstraZeneca and Renedil by Sanofi-Aventis. The formulation patent for the substance expired in 2007. AstraZeneca dropped Plendil from its support and AZ&Me free Rx access program in October 2008. (Wikipedia)

Cimicoxib

4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl]benzene-1-sulfonamide

C16H13ClFN3O3S (381.035)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid

2-(4-{[(3,5-dichlorophenyl)-C-hydroxycarbonimidoyl]methyl}phenoxy)-2-methylpropanoate

C18H17Cl2NO4 (381.0535)

CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2012

dehydrofelodipine

Dehydro Felodipine

C18H17Cl2NO4 (381.0535)

N-Acetylgalactosamine 4,6-disulfate

C8H15NO12S2 (381.0036)

(CYANOMETHYL)TRIPHENYLPHOSPHONIUM BROMIDE

C20H17BrNP (381.0282)

Cobalt(2+) bis(4-oxo-4-phenyl-2-buten-2-olate)

C20H18CoO4 (381.0537)

Descarbamoyl Cefuroxime

C15H15N3O7S (381.0631)

O,O-Diethylthiophosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate

C11H16N3O6PS2 (381.0218)

4-(4-chlorophenylmethyl)-6,7-dimethoxy-isoquinoline methanesulfonate (1:1)

C17H16ClNO5S (381.0438)

NXY-059

Disufenton sodium

C11H13NNa2O7S2 (380.9929)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant D002317 - Cardiovascular Agents

Platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane

C8H18OPtSi2 (381.0544)

Mebutizide

6-chloro-3-(3-methylpentan-2-yl)-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide

C13H20ClN3O4S2 (381.0584)

C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

5-[(4-acetylbenzoyl)amino]-2-ethoxybenzenesulfonyl chloride

C17H16ClNO5S (381.0438)

(6R,7R)-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H15N3O7S (381.0631)

[5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazin-6-yl]methanol

C17H11ClF3N3O2 (381.0492)

((2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-nitrophenoxy)tetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate

C12H16NO11P (381.0461)

2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid

C18H17Cl2NO4 (381.0535)

(5Z)-5-(3-Bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydro[1,2,4]triazolo[1,5-A]pyrimidin-7-amine

C17H14BrN6+ (381.0463)

N-(hydroxymethyl)-N-{propyl[2-(2,4,6-trichlorophenoxy)ethyl]carbamoyl}methanimidamide

C14H18Cl3N3O3 (381.0414)

(4S)-2-acetyl-3,4,8,10,11,12-hexahydroxy-1,4-dihydrotetracen-1-one

C20H13O8- (381.061)

[4,5-Dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate

C20H13O8- (381.061)

2-acetamido-2-deoxy-4,6-di-O-sulfo-beta-D-galactopyranose

C8H15NO12S2 (381.0036)

p-Nitrophenyl alpha-glucoside 6-phosphate

C12H16NO11P (381.0461)

2-[[[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxy-hydroxyphosphoryl]methylamino]acetic acid

C8H17NO12P2 (381.0226)

N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamide

C19H15N3O2S2 (381.0606)

N-[[3-chloro-4-(4-morpholinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

C16H16ClN3O2S2 (381.0372)

4,5-Dichloro-2-[2-[2,5-dimethyl-1-(2,2,2-trifluoroethyl)-3-pyrrolyl]-2-oxoethyl]-3-pyridazinone

C14H12Cl2F3N3O2 (381.0259)

5-(1,3-benzodioxol-5-yl)-3-phenyl-2-sulfanylidene-4H-thiazolo[4,5-d]pyrimidin-7-one

C18H11N3O3S2 (381.0242)

4-[[(3,6-Dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl ester

C18H17Cl2NO4 (381.0535)

(E)-2-methylsulfonyl-3-[1-(4-nitrophenyl)sulfonylpyrrol-2-yl]prop-2-enenitrile

C14H11N3O6S2 (381.0089)

1-(3,4-Dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)thiourea

C14H9Cl2N5S2 (380.9676)

6-(Bromomethyl)-1,3-dimethyl-5-[(4-nitrophenyl)-oxomethyl]pyrimidine-2,4-dione

C14H12BrN3O5 (380.996)

2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid [2-(2,5-dichloroanilino)-2-oxoethyl] ester

C17H13Cl2NO5 (381.0171)

2-(7-Bromo-1-methyl-5-triazolo[4,5-c]pyridin-5-iumyl)-1-(2-naphthalenyl)ethanone

C18H14BrN4O+ (381.0351)

lissamine flavine FF(1-)

C19H13N2O5S- (381.0545)

4-nitrophenyl 6-O-phosphono-beta-D-galactoside

C12H16NO11P (381.0461)

4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzoic acid

C20H15NO3S2 (381.0493)

4-chloro-N-[(2S)-5-hydroxy-2-methyl-2,3-dihydroindol-1-yl]-3-sulfamoylbenzamide

C16H16ClN3O4S (381.055)

N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxotetrazol-1-yl]phenyl]ethanesulfonamide

C12H14ClF2N5O3S (381.0474)

Cimicoxib

C16H13ClFN3O3S (381.035)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

Desacetycefapirin

C15H15N3O5S2 (381.0453)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams